Sign In
Last checked at 
23 Mar 2009 07:00
ο»Ώ
|
For Immediate Release |
23Β March 2009 |
ImmuPharma PLC
Directors' Dealings
Institutions increase stake
Β
ImmuPharma PLCΒ ("ImmuPharma" or the "Company")Β (LSE:IMM)Β announcesΒ todayΒ thatΒ a number of existing and new blue-chip institutional investors have purchased shares from the Trusts of two ofΒ ImmuPharma's founders and Directors, Richard Warr and Dimitri Dimitriou.Β The Trusts eachΒ placedΒ 2.1 millionΒ (2.7Β %)Β ordinary sharesΒ of 10 pence eachΒ in the CompanyΒ at a price ofΒ 82Β pence per shareΒ to institutional investorsΒ on 19 March.
Β
Following the disposal, the current holdings are:
|
Richard WarrΒ (1) |
9,778,968 ordinary shares |
(12.6 %) |
|
Dimitri DimitriouΒ (2) |
9,778,969 ordinary shares |
(12.6 %) |
(1) Ordinary shares of Β£0.10 held byΒ Louvre TrusteesΒ LimitedΒ where the Warr family has a beneficial interest.Β
(2) Ordinary shares of Β£0.10 held by Louvre TrusteesΒ LimitedΒ where the Dimitriou family has a beneficial interest.Β
Β
Richard Warr, ImmuPharma's Chairman said:Β
"We are delighted with the demand fromΒ newΒ investors,Β including several blue-chip fundsΒ such asΒ Gartmore, Smith & Williamson, Aviva and Rathbones.Β Β The allocation of these shares increases ImmuPharma's free float with the aim of improving overall liquidity."
For further information please contact:Β
|
ImmuPharma PLC: |
+44 20 7152 4080 |
|
Dimitri Dimitriou, Chief Executive OfficerΒ |
|
|
Richard Warr, Chairman |
|
|
Panmure Gordon |
+44 151 243 0963 |
|
Andrew Burnett/ Rakesh Sharma (Corporate Finance) |
|
|
Ashton Clanfield (Corporate Broking) |
|
|
Buchanan Communications: |
+44 20 7466 5000 |
|
Lisa BaderoonΒ |
|
|
Rebecca Skye Dietrich |
More information on the company can be found at www.immupharma.com
Follow the stocks
